HARP insider filings

Harpoon Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-03-11. Screen HARP transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for HARP between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Harpoon Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2024-03-114Chin Mark — DirectorGrant/award (A): 424 @ $0 · Disposition to issuer (D): 13,224 · Disposition to issuer (D): 2,033 (derivative) · Disposition to issuer (D): 1,016 (derivative) · Disposition to issuer (D): 3,214 (derivative) · Disposition to issuer (D): 2,300 (derivative)EDGAR
2024-03-114Merck & Co., Inc. — 10% owner
MERCK SHARP & DOHME LLC — 10% owner
Purchase (P): 21,397,205 @ $23EDGAR
2024-03-114Walker Luke Nathaniel — Chief Medical OfficerDisposition to issuer (D): 135,000 · Disposition to issuer (D): 30,500 (derivative) · Disposition to issuer (D): 10,000 (derivative)EDGAR
2024-03-114Bucher James B — Chief Legal OfficerDisposition to issuer (D): 110,000 (derivative)EDGAR
2024-03-114Lanza Frank J — Principal Fin. & Acctng Ofc.Disposition to issuer (D): 18,734 · Disposition to issuer (D): 8,643 (derivative) · Disposition to issuer (D): 6,499 (derivative)EDGAR
2024-03-114Robbins Andrew R — DirectorDisposition to issuer (D): 5,000 · Disposition to issuer (D): 1,016 (derivative) · Disposition to issuer (D): 2,300 (derivative)EDGAR
2024-03-114DRACHMAN JONATHAN G — DirectorGrant/award (A): 415 @ $0 · Disposition to issuer (D): 5,415 · Disposition to issuer (D): 5,531 (derivative) · Disposition to issuer (D): 1,016 (derivative) · Disposition to issuer (D): 2,300 (derivative)EDGAR
2024-03-114EASTLAND JULIA MARIE — President and CEO, DirectorGrant/award (A): 31,250 @ $0 · Disposition to issuer (D): 269,381 · Disposition to issuer (D): 2,765 (derivative) · Disposition to issuer (D): 40,759 (derivative)EDGAR
2024-03-114Myers Scott Dunseth — DirectorDisposition to issuer (D): 22,665 · Disposition to issuer (D): 2,033 (derivative) · Disposition to issuer (D): 4,600 (derivative)EDGAR
2024-03-114New Leaf Biopharma Opportunities II, L.P. — Director, 10% owner
New Leaf Ventures III, L.P. — Director, 10% owner
New Leaf Venture Associates III, L.P. — Director, 10% owner
New Leaf Venture Management III, L.L.C. — Director, 10% owner
New Leaf BPO Associates II, L.P. — Director, 10% owner
New Leaf BPO Management II, L.L.C — Director, 10% owner
Lathi Vijay K — Director, 10% owner
Disposition to issuer (D): 1,463,386 · Disposition to issuer (D): 395,783 · Disposition to issuer (D): 10,000 · Disposition to issuer (D): 299,430 (derivative) · Disposition to issuer (D): 686,000 (derivative) · Disposition to issuer (D): 85,750 (derivative)EDGAR
2024-03-114HUNT RONALD — Director, 10% ownerGrant/award (A): 424 @ $0 · Disposition to issuer (D): 13,224 · Disposition to issuer (D): 1,463,386 · Disposition to issuer (D): 395,783 · Disposition to issuer (D): 10,000 · Disposition to issuer (D): 299,430 (derivative) · +6 moreEDGAR
2024-03-114SILVERNAIL LAUREN P — DirectorDisposition to issuer (D): 5,000 · Disposition to issuer (D): 2,033 (derivative) · Disposition to issuer (D): 2,300 (derivative)EDGAR
2024-03-114BAILES JOSEPH S — DirectorDisposition to issuer (D): 5,000 · Disposition to issuer (D): 1,016 (derivative) · Disposition to issuer (D): 3,142 (derivative) · Disposition to issuer (D): 2,300 (derivative)EDGAR
2024-01-094Walker Luke Nathaniel — Chief Medical OfficerGrant/award (A): 115,000 @ $0EDGAR
2024-01-094Lanza Frank J — Principal Fin. & Acctng Ofc.Grant/award (A): 15,000 @ $0EDGAR
2024-01-094EASTLAND JULIA MARIE — President and CEO, DirectorGrant/award (A): 178,500 @ $0EDGAR
2024-01-034Chin Mark — DirectorGrant/award (A): 1,072 @ $0EDGAR
2024-01-034Myers Scott Dunseth — DirectorGrant/award (A): 2,048 @ $0EDGAR
2024-01-034HUNT RONALD — Director, 10% ownerGrant/award (A): 1,072 @ $0EDGAR
2023-12-264Bucher James B — Chief Legal OfficerGrant/award (A): 110,000 (derivative) @ $0EDGAR
2023-11-284Chin Mark — DirectorGrant/award (A): 5,000 @ $0EDGAR
2023-11-284Walker Luke Nathaniel — Chief Medical OfficerGrant/award (A): 20,000 @ $0EDGAR
2023-11-284Lanza Frank J — Principal Fin. & Acctng Ofc.Grant/award (A): 2,000 @ $0EDGAR
2023-11-284Robbins Andrew R — DirectorGrant/award (A): 5,000 @ $0EDGAR
2023-11-284DRACHMAN JONATHAN G — DirectorGrant/award (A): 5,000 @ $0EDGAR
2023-11-284EASTLAND JULIA MARIE — President and CEO, DirectorGrant/award (A): 50,000 @ $0EDGAR
2023-11-284Myers Scott Dunseth — DirectorGrant/award (A): 5,000 @ $0EDGAR
2023-11-284HUNT RONALD — Director, 10% ownerGrant/award (A): 5,000 @ $0EDGAR
2023-11-284SILVERNAIL LAUREN P — DirectorGrant/award (A): 5,000 @ $0EDGAR
2023-11-284BAILES JOSEPH S — DirectorGrant/award (A): 5,000 @ $0EDGAR
2023-10-274New Leaf Biopharma Opportunities II, L.P. — 10% owner
New Leaf Ventures III, L.P. — 10% owner
New Leaf Venture Associates III, L.P. — 10% owner
New Leaf Venture Management III, L.L.C. — 10% owner
New Leaf BPO Associates II, L.P. — 10% owner
New Leaf BPO Management II, L.L.C — 10% owner
Lathi Vijay K — 10% owner
Purchase (P): 1,372,000 · Purchase (P): 171,500 · Purchase (P): 686,000 (derivative) · Purchase (P): 85,750 (derivative)EDGAR
2023-10-274HUNT RONALD — Director, 10% ownerPurchase (P): 1,372,000 · Purchase (P): 171,500 · Purchase (P): 686,000 (derivative) · Purchase (P): 85,750 (derivative)EDGAR
2023-10-024Chin Mark — DirectorGrant/award (A): 3,035 @ $0EDGAR
2023-10-024Myers Scott Dunseth — DirectorGrant/award (A): 5,797 @ $0EDGAR
2023-10-024HUNT RONALD — Director, 10% ownerGrant/award (A): 3,035 @ $0EDGAR
2023-07-064Chin Mark — DirectorGrant/award (A): 18,656 @ $0EDGAR
2023-07-064Myers Scott Dunseth — DirectorGrant/award (A): 35,634 @ $0EDGAR
2023-07-064HUNT RONALD — Director, 10% ownerGrant/award (A): 18,656 @ $0EDGAR
2023-06-234Chin Mark — DirectorGrant/award (A): 23,000 (derivative) @ $0EDGAR
2023-06-234Robbins Andrew R — DirectorGrant/award (A): 23,000 (derivative) @ $0EDGAR
2023-06-234DRACHMAN JONATHAN G — DirectorGrant/award (A): 23,000 (derivative) @ $0EDGAR
2023-06-234Myers Scott Dunseth — DirectorGrant/award (A): 46,000 (derivative) @ $0EDGAR
2023-06-234HUNT RONALD — Director, 10% ownerGrant/award (A): 23,000 (derivative) @ $0EDGAR
2023-06-234SILVERNAIL LAUREN P — DirectorGrant/award (A): 23,000 (derivative) @ $0EDGAR
2023-06-234BAILES JOSEPH S — DirectorGrant/award (A): 23,000 (derivative) @ $0EDGAR
2023-04-044Viney Joanne L. — DirectorGrant/award (A): 21,028 @ $0EDGAR
2023-04-044Chin Mark — DirectorGrant/award (A): 18,285 @ $0EDGAR
2023-04-044Myers Scott Dunseth — DirectorGrant/award (A): 34,925 @ $0EDGAR
2023-04-044Colowick Alan — DirectorGrant/award (A): 16,456 @ $0EDGAR
2023-04-044HUNT RONALD — Director, 10% ownerGrant/award (A): 18,285 @ $0EDGAR

Recent 8-K events — Harpoon Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-03-118-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2024-03-088-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2024-02-288-K8.01 — Other EventsEDGAR
2024-02-228-K8.01 — Other EventsEDGAR
2024-01-298-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-268-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-088-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-248-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=HARP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs